Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Has Christian Leone Cut Back His Stake In Altisource Portfolio Solutions S.A. (ASPS) Too Early?

Page 1 of 2

In a Form 4 filed with the Securities and Exchange Commission, Christian Leone’s Luxor Capital Group has disclosed sales on July 23 of 362,150 shares in Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) at prices ranging from $39.50 to $39.90. In its most recent 13F filing, Luxor Capital Group disclosed an ownership stake of 2.38 million shares in Altisource Portfolio Solutions. The fund now holds just under 1.87 million shares of the company, a 9.98% stake.

Christian Leone

Luxor Capital Group is a multi-billion dollar hedge fund established and managed by Christian Leone. The New York-based hedge fund mainly invests in special situations, equity of distressed companies and global debt by employing a value-oriented stock picking approach. The investment management firm manages several separate client-focused equity, fixed income and balanced portfolios. The fund’s most recent 13F filing with the SEC for the March 31 reporting period reveals that it manages a public equity portfolio worth $6.19 billion, while its holdings are diversified among the following sectors: 47.52% in the services sector, 13.56% in the technology sector, and 8.36% and 5.19% in the financial and transportation sectors, respectively. In addition to that, the public equity portfolio managed by Christian Leone and his team is highly concentrated, with the top ten positions representing 66.52% of its entire portfolio.

Christian Leone
Christian Leone
Luxor Capital Group

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 123% over the ensuing 34 months, outperforming the S&P 500 Index by nearly 67 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) is a marketplace and transaction solutions provider for the real estate, mortgage, and consumer debt industries in the United States.  The company’s proprietary business processes, vendor and electronic payment management software, and behavioral science-based analytics improve outcomes for marketplace participants such as sub-prime servicers, utility companies, commercial banks, mortgage bankers, and investors, among others. The shares of Altisource Portfolio Solutions have grown by over 14% year-to-date despite suffering serious slumps at the beginning of the year.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!